ApoVax104-HPV

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameApoVax104-HPV
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccineBiologics > Antigen > Tumor antigen
Mechanisms of ActionProtein E7 modulators
TargetsProtein E7
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApoVax Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApoVax Inc
Active IndicationsN/A
Inactive IndicationsUterine Cervical Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A